- Home
- INAB vs DLPN Comparison
INAB vs DLPN Comparison
Compare INAB & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- DLPN
- Stock Information
- Founded
- INAB 2016
- DLPN 1996
- Country
- INAB United States
- DLPN United States
- Employees
- INAB N/A
- DLPN N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- DLPN Other Consumer Services
- Sector
- INAB Health Care
- DLPN Consumer Discretionary
- Exchange
- INAB Nasdaq
- DLPN Nasdaq
- Market Cap
- INAB 14.5M
- DLPN 12.3M
- IPO Year
- INAB 2021
- DLPN N/A
- Fundamental
- Price
- INAB $2.49
- DLPN $1.27
- Analyst Decision
- INAB Strong Buy
- DLPN Strong Buy
- Analyst Count
- INAB 2
- DLPN 1
- Target Price
- INAB $108.00
- DLPN $5.00
- AVG Volume (30 Days)
- INAB 185.2K
- DLPN 31.7K
- Earning Date
- INAB 08-07-2025
- DLPN 08-13-2025
- Dividend Yield
- INAB N/A
- DLPN N/A
- EPS Growth
- INAB N/A
- DLPN N/A
- EPS
- INAB N/A
- DLPN N/A
- Revenue
- INAB N/A
- DLPN $48,618,803.00
- Revenue This Year
- INAB N/A
- DLPN $6.57
- Revenue Next Year
- INAB N/A
- DLPN $18.10
- P/E Ratio
- INAB N/A
- DLPN N/A
- Revenue Growth
- INAB N/A
- DLPN 0.31
- 52 Week Low
- INAB $2.05
- DLPN $0.75
- 52 Week High
- INAB $27.30
- DLPN $2.00
- Technical
- Relative Strength Index (RSI)
- INAB 44.14
- DLPN 65.72
- Support Level
- INAB $2.10
- DLPN $1.07
- Resistance Level
- INAB $2.30
- DLPN $1.39
- Average True Range (ATR)
- INAB 0.13
- DLPN 0.08
- MACD
- INAB 0.10
- DLPN 0.02
- Stochastic Oscillator
- INAB 96.70
- DLPN 78.13
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.